DigiFT and Chainlink Collaborate To Power Institutional-Grade Tokenization of RWAs
The
DigiFT, which provides financial services for primary issuance and secondary market trading, will benefit from enhanced liquidity for its real-world assets (RWA) tokens by adopting CCIP for secure cross-chain token transfers across multiple chains and as a result improve liquidity on secondary trading markets. Increased liquidity can enable more efficient markets and encourage institutional asset managers to incorporate tokenized assets in their investment strategies. Through the application of CCIP and Proof of Reserve, DigiFT and Chainlink are collaborating to drive institutional adoption of public blockchain and tokenization technology.
"Chainlink CCIP is a foundational technology for enhancing blockchain-based capabilities through secure and seamless interoperability," said
"Chainlink CCIP and Proof of Reserve are crucial components for both onchain protocols and traditional financial institutions. We look forward to working with DigiFT to expand the utility and accessibility of their tokenized RWAs with the Chainlink platform," said
Chainlink
Chainlink is the universal platform for pioneering the future of global markets onchain. Chainlink has enabled over
About DigiFT
DigiFT is
Established in
DigiFT's founding team consists of seasoned executives who have held senior positions at Citi, Standard Chartered Bank, Morgan Stanley, and the Shenzhen Stock Exchange. Their combined expertise spans both traditional and decentralized finance, demonstrating proven track records in the digital assets space.
View original content to download multimedia:https://www.prnewswire.com/news-releases/digift-and-chainlink-collaborate-to-power-institutional-grade-tokenization-of-rwas-302286459.html
SOURCE Chainlink; DigiFT
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Monster Energy Riders Claim Key Victories on Day 2 of X Games Sacramento 2026
- BridgeBio Announces Publication in the New England Journal of Medicine of Phase 3 PROPEL 3 Trial of Oral Infigratinib in Children Living with Achondroplasia
- Dogecoin Price Prediction 2026: Can DOGE Run, and Why Early Buyers Are Joining the Bullski Priority List
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Citi, Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share